Core Insights - The main viewpoint of the article highlights the limitations of traditional mental health diagnostic methods and introduces a non-invasive brain-computer interface technology as a more efficient and objective solution for diagnosing conditions like depression and anxiety [1] Group 1: Current Diagnostic Methods - Current mainstream methods for diagnosing mental health issues rely on a combination of "scale assessment + comprehensive judgment by doctors," which is time-consuming and difficult to quantify [1] - In non-hospital settings, such as community screenings or corporate health management, the lack of professional psychological resources can lead to subjective biases in results [1] Group 2: Innovative Solutions - The non-invasive brain-computer interface technology offers a solution by utilizing real-time EEG signal collection and AI analysis for efficient and objective assessments [1] - The core competitive advantage of Haoshi Tianhui lies in its fully self-developed non-invasive brain-computer interface technology system, which includes high-precision AI algorithms that decode EEG signals into quantifiable emotional indicators [1] Group 3: Product Features and Efficacy - The developed system can conduct tests for depression and anxiety in as little as 90 seconds per session, achieving an accuracy rate of over 90% [1] - The system has received medical device registration certification and integrates a software platform that generates customized therapeutic music based on real-time EEG data, creating a complete "assessment-intervention-feedback" loop [1] Group 4: Market Potential and Expansion - The solution significantly reduces subjective bias and enhances screening efficiency, making it applicable in various settings such as hospitals, education, and justice [1] - Recent policy support in China for mental health diagnosis, including the incorporation of AI+EEG diagnostics into national medical guidelines, creates favorable commercialization conditions [1] - Haoshi Tianhui has initiated collaborations with medical institutions and distributors in regions like Yunnan, Guizhou, Sichuan, Jiangxi, Guangdong, Hebei, and Jiangsu-Zhejiang-Shanghai to accelerate product scaling [1] - Future plans include expanding into consumer applications through the sale of devices and consumables, as well as a system service model to achieve sustainable revenue growth [1]